Dr Reddy’s Laboratories reeled early Monday, plunging 9% after the New Jersey District Court granted a preliminary injunction against the sale of the generic version of Suboxone used for treating opioid dependence.
The stock crashed 9.48% to hit a low of Rs 2,097.70 on the BSE.
The stock crashed 9.48% to hit a low of Rs 2,097.70 on the BSE.
For Real Time News & Trading Trends Keep Liking Epic Research Limited
For more information on Equity Market News Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
No comments:
Post a Comment